Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22327497 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines;   Tetanus
Interventions: Biological: Boostrix Polio™ 711866;   Biological: Priorix Tetra TM 208136;   Biological: Tetravac TM

Indicates status has not been verified in more than two years